Aurora Cannabis Inc (ACB) is a well-known company in the global cannabis industry, operating across 25 countries. Headquartered in Edmonton, Alberta, Canada, the company is publicly traded on the Toronto Stock Exchange and the New York Stock Exchange since October 2018. ACB is committed to setting the highest standards for product quality, client services, and innovative developments within this burgeoning industry.
Aurora specializes in the production and distribution of medical cannabis, with a broad and extensive product portfolio that includes dried cannabis, cannabis oil, softgels, oral dissolvable wafers, vaporizer, and topicals. The company’s products are designed to serve an array of cannabis markets, including medical patients, adult-use consumers, and wellness-focused consumers.
ACB's medical cannabis business is its core strength, recognized by physician and patient communities worldwide. It has a robust medical research strategy, partnering with globally acclaimed research-focused organizations, resulting in several initiated clinical trials and case studies with the goal of advancing knowledge of cannabinoids as medically therapeutic solutions.
Aurora is serving the consumer market under numerous well-reputed brands that cater to an array of consumer preferences. Since the legalization of recreational cannabis in Canada in October 2018, Aurora has proven itself as a dominant player in this market segment as well.
Aside from its primary business activities, ACB is also committed to sustainability and community engagement. The company operates with an environmentally friendly approach, using purpose-built indoor cannabis facilities with advanced climate control systems that reduce waste and energy usage. Aurora frequently gives back to the communities in which it operates, notably through job creation, investing in local infrastructure, and supporting local charities and non-profit organizations.
However, the rapid growth and regulatory changes in the cannabis industry have given rise to challenges for most cannabis companies including ACB. Slower than expected retail rollouts and over-supply situations have affected the sales and profitability of the industry, leading to a downturn in Aurora’s stock prices.
Despite these challenges, Aurora Cannabis Inc continues to shape the future of cannabis as a leading player in this growing sector - building high-quality cannabis products, investing in research and development, and generating significant employment to create a robust and sustainable industry.